• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • The Congolese philosopher who liberated ‘Africa’ from the chains of Western thought
    • Why US court’s fine on Israeli firm operating Pegasus is an indictment of the Indian Supreme Court
    • Four questions Indians must ask about Operation Sindoor
    • ‘By tearing off the skin with your teeth’: The right way to eat mangoes according to Victorian women
    • The 2025 Pulitzer Prizes: A readers’ guide to the seven winning books
    • Madhya Pradesh minister apologises for remark about Colonel Sofia Qureshi
    • India hyphen Pakistan: US rhetoric revives New Delhi’s nightmare
    • Don’t penalise Modi government for seeking peaceful resolution to Pakistan conflict: Mehbooba Mufti
    • Madhya Pradesh HC orders FIR against BJP leader for remark about Colonel Sofia Qureshi
    • Why workers at an Adani power plant who gave up land for jobs went on a hunger strike
    • It’s getting impossible to tell AI images apart from real ones – new labelling system could help
    • Rush Hour: BJP leader to be booked for remark about Colonel Sofia Qureshi, new CJI sworn in and more
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

Roche

  • HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest

    HC allows Natco Pharma to make Swiss firm Roche’s spinal muscular atrophy drug in public interest

    Scroll Staff
    · Mar 26, 2025 · 01:25 pm
  • Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

    Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

    Dinesh Thakur Prashant Reddy T
    · Mar 07, 2024 · 09:00 am
  • Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose

    Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose

    Scroll Staff
    · May 25, 2021 · 07:48 am
  • Competition Commission of India pulls up Roche for anti-competitive practices

    Competition Commission of India pulls up Roche for anti-competitive practices

    Jyotsna Singh
    · Apr 26, 2017 · 08:30 pm
  • Photos: Why women and men wearing bras ambushed a pharma giant in Durban

    Photos: Why women and men wearing bras ambushed a pharma giant in Durban

    Priyanka Vora
    · Jul 21, 2016 · 09:00 pm